| Autor: |
Kaur, Mandeep, Fusco, Salvatore, Van den Broek, Bram, Aseervatham, Jaya, Rostami, Abdolmohamad, Iacovitti, Lorraine, Grassi, Claudio, Lukomska, Barbara, Srivastava, Amit K. |
| Předmět: |
|
| Zdroj: |
Medicinal Research Reviews; Jul2024, Vol. 44 Issue 4, p1923-1966, 44p |
| Abstrakt: |
Over the past few decades, there has been a notable increase in the global burden of central nervous system (CNS) diseases. Despite advances in technology and therapeutic options, neurological and neurodegenerative disorders persist as significant challenges in treatment and cure. Recently, there has been a remarkable surge of interest in extracellular vesicles (EVs) as pivotal mediators of intercellular communication. As carriers of molecular cargo, EVs demonstrate the ability to traverse the blood–brain barrier, enabling bidirectional communication. As a result, they have garnered attention as potential biomarkers and therapeutic agents, whether in their natural form or after being engineered for use in the CNS. This review article aims to provide a comprehensive introduction to EVs, encompassing various aspects such as their diverse isolation methods, characterization, handling, storage, and different routes for EV administration. Additionally, it underscores the recent advances in their potential applications in neurodegenerative disorder therapeutics. By exploring their unique capabilities, this study sheds light on the promising future of EVs in clinical research. It considers the inherent challenges and limitations of these emerging applications while incorporating the most recent updates in the field. Highlights: 1.Extracellular vesicles (EVs) exhibit a nuanced dual role in nervous system pathologies, acting as agents that either promote physiological processes or contribute to pathological conditions.2.The small size of EVs enables them to navigate physiological barriers, such as the blood‐brain barrier (BBB), facilitating their access to the intricate neural environment.3.With immediate transport and targeting benefits, EVs exhibit long‐term stability, enhancing their viability as therapeutic agents. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text